Journal of Molecular and Cellular Cardiology
Volume 52, Issue 3 , Pages 689-700, March 2012

Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease

Received 26 July 2011; received in revised form 1 December 2011; accepted 29 December 2011. published online 11 January 2012.

Abstract 

Studies of human diseased aortic valves have demonstrated increased expression of genetic markers of valve progenitors and osteogenic differentiation associated with pathogenesis. Three potential mouse models of valve disease were examined for cellular pathology, morphology, and induction of valvulogenic, chondrogenic, and osteogenic markers. Osteogenesis imperfecta murine (Oim) mice, with a mutation in Col1a2, have distal leaflet thickening and increased proteoglycan composition characteristic of myxomatous valve disease. Periostin null mice also exhibit dysregulation of the ECM with thickening in the aortic midvalve region, but do not have an overall increase in valve leaflet surface area. Klotho null mice are a model for premature aging and exhibit calcific nodules in the aortic valve hinge-region, but do not exhibit leaflet thickening, ECM disorganization, or inflammation. Oim/oim mice have increased expression of valve progenitor markers Twist1, Col2a1, Mmp13, Sox9 and Hapln1, in addition to increased Col10a1 and Asporin expression, consistent with increased proteoglycan composition. Periostin null aortic valves exhibit relatively normal gene expression with slightly increased expression of Mmp13 and Hapln1. In contrast, Klotho null aortic valves have increased expression of Runx2, consistent with the calcified phenotype, in addition to increased expression of Sox9, Col10a1, and osteopontin. Together these studies demonstrate that oim/oim mice exhibit histological and molecular characteristics of myxomatous valve disease and Klotho null mice are a new model for calcific aortic valve disease.

Highlights

► Osteogenesis imperfecta mice have myxomatous valve disease. ► Klotho null mice have calcific aortic valve disease without inflammation. ► Mouse models have differential expression of valvulogenic, cartilage and bone genes. ► Valve disease in mice can occur without myofibroblast activation.

Abbreviations: CAVD, Calcific aortic valve disease, BAV, Bicuspid aortic valve, OI, Osteogenesis imperfecta, pHH3, Phospho-histone H3, SMA, Smooth muscle α-actin, ECM, Extracellular matrix, VIC, Valve interstitial cell

Keywords: Aortic valve disease, Valvular interstitial cells, Calcification, Extracellular matrix, Mouse models of human disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-2828(12)00002-8

doi:10.1016/j.yjmcc.2011.12.013

Journal of Molecular and Cellular Cardiology
Volume 52, Issue 3 , Pages 689-700, March 2012